封面
市场调查报告书
商品编码
1748745

局部给药市场-全球产业规模、份额、趋势、机会与预测,依产品、给药途径、最终用户、地区及竞争细分,2020-2030 年预测

Topical Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Route of Administration, By End-User, By Region, & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球局部给药市场价值为 2,443.5 亿美元,预计到 2030 年将达到 4,051 亿美元,复合年增长率为 8.75%。这一增长是由对非侵入性标靶治疗日益增长的需求推动的,尤其是在老年人、儿童和慢性病患者等弱势群体中。局部给药直接应用于皮肤或黏膜组织,因其局部治疗效果和最小的全身暴露而受到青睐。脂质系统和微针贴片等製剂技术的创新,加上简化的监管途径,进一步支持了市场扩张。此外,不断增长的健康意识正在推动外用和透皮产品在皮肤病学、伤口护理和疼痛管理中的应用。随着製药公司转向更加以患者为中心和对门诊患者友好的解决方案,局部给药正在成为现代医疗保健策略不可或缺的一部分。

市场概览
预测期 2026-2030
2024年市场规模 2443.5亿美元
2030年市场规模 4051亿美元
2025-2030 年复合年增长率 8.75%
成长最快的领域 透皮产品
最大的市场 北美洲

关键市场驱动因素

皮肤病和慢性病盛行率上升

主要市场挑战

有限的皮肤渗透性和配方复杂性

主要市场趋势

先进药物传输技术的应用日益广泛

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:局部给药市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 副产品(半固体製剂、液体製剂、固体製剂、透皮产品)
    • 依给药途径(皮肤给药、眼部给药、直肠给药、鼻腔给药)
    • 按最终使用者(医院、诊所、家庭医疗保健、诊断中心等)
    • 按地区
    • 按公司分类(2024)
  • 市场地图

第六章:北美局部给药市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲局部给药市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第八章:亚太地区局部给药市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美局部给药市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东和非洲局部给药市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章:全球局部给药市场:SWOT 分析

第 14 章:竞争格局

  • Johnson & Johnson Services, Inc.
  • Nestle SA
  • GlaxoSmithKline Plc
  • Novartis AG
  • Merck & Co. Inc.
  • Crescita Therapeutics Inc.
  • Cipla Ltd.
  • Taro Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International Inc.
  • Glenmark Pharmaceuticals Ltd.

第 15 章:策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 7362

The Global Topical Drug Delivery Market was valued at USD 244.35 Billion in 2024 and is projected to reach USD 405.10 Billion by 2030, growing at a CAGR of 8.75%. This growth is driven by the increasing demand for non-invasive, targeted therapies, especially among vulnerable populations such as the elderly, children, and those with chronic conditions. Topical drug delivery, which involves direct application to the skin or mucosal tissues, is favored for its localized therapeutic effects and minimal systemic exposure. Market expansion is further supported by innovations in formulation technologies like lipid-based systems and microneedle patches, coupled with streamlined regulatory pathways. Additionally, growing health awareness is boosting the adoption of topical and transdermal products in dermatology, wound care, and pain management. As pharmaceutical firms pivot toward more patient-centric and outpatient-friendly solutions, topical drug delivery is becoming an integral part of modern healthcare strategies.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 244.35 Billion
Market Size 2030USD 405.10 Billion
CAGR 2025-20308.75%
Fastest Growing SegmentTransdermal Products
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Skin Disorders and Chronic Diseases

Skin disorders are among the most widespread medical conditions globally, impacting individuals of all ages. The growing incidence of issues such as acne, eczema, psoriasis, dermatitis, fungal infections, and rosacea is linked to changing environmental factors, lifestyle habits, genetic predispositions, and heightened diagnosis rates. According to the Global Burden of Disease Study, over 1.9 billion people are affected by skin conditions worldwide, making it a critical public health concern. Chronic skin ailments often require continuous or recurring treatment, with topical formulations offering targeted application and fewer systemic side effects. Acne alone affects approximately 9.4% of the global population and ranks as the eighth most prevalent skin disease. Its high incidence, particularly among adolescents and young adults-where rates can reach 28.3%-creates a robust market opportunity for both over-the-counter and prescription topical treatments. This sustained and growing prevalence ensures consistent demand for topical dermatological products.

Key Market Challenges

Limited Skin Permeability and Formulation Complexity

A key obstacle to market advancement is the restricted permeability of human skin, especially when attempting to deliver drugs with large molecular sizes, hydrophilic properties, or instability. The outermost skin layer, the stratum corneum, serves as a significant barrier to most active pharmaceutical ingredients, particularly biologics, proteins, and peptides. Successfully formulating compounds that can penetrate this layer without compromising safety and efficacy remains a technical challenge. Furthermore, the development of innovative topical delivery systems-such as microneedles, nano-based carriers, or vesicular formulations-demands substantial R&D investment, specialized knowledge, and intricate manufacturing processes. These challenges constrain the variety of drugs suitable for topical delivery and lead to extended product development timelines and increased costs.

Key Market Trends

Growing Adoption of Advanced Drug Delivery Technologies

A prominent trend in the topical drug delivery market is the increased adoption of advanced technologies aimed at enhancing drug stability, skin penetration, and bioavailability. Nanotechnology-enabled systems, including liposomes, niosomes, and solid lipid nanoparticles, are facilitating deeper and more targeted delivery of active ingredients. Additionally, devices like microneedle patches and transdermal systems are opening up new possibilities for administering complex molecules such as peptides and vaccines through the skin. These innovations not only improve treatment outcomes but also extend product lifecycles and enable differentiation in competitive markets. The ability to provide controlled, localized, and sustained drug release is drawing investment and driving robust R&D across the pharmaceutical landscape.

Key Market Players

  • Johnson & Johnson Services, Inc.
  • Nestle SA
  • GlaxoSmithKline Plc
  • Novartis AG
  • Merck & Co. Inc.
  • Crescita Therapeutics Inc.
  • Cipla Ltd.
  • Taro Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International Inc.
  • Glenmark Pharmaceuticals Ltd

Report Scope:

In this report, the Global Topical Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Topical Drug Delivery Market, By Product:

  • Semi-Solid Formulations
  • Liquid Formulations
  • Solid Formulations
  • Transdermal Products

Topical Drug Delivery Market, By Route of Administration:

  • Dermal Drug Delivery
  • Ophthalmic Drug Delivery
  • Rectal Drug Delivery
  • Nasal Drug Delivery

Topical Drug Delivery Market, By End User:

  • Hospitals
  • Clinics
  • Home Healthcare
  • Diagnostic Centers
  • Others

Topical Drug Delivery Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Topical Drug Delivery Market.

Available Customizations:

Global Topical Drug Delivery market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Topical Drug Delivery Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products)
    • 5.2.2. By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Nasal Drug Delivery)
    • 5.2.3. By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Topical Drug Delivery Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Route of Administration
    • 6.2.3. By End-User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Topical Drug Delivery Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Route of Administration
        • 6.3.1.2.3. By End-User
    • 6.3.2. Canada Topical Drug Delivery Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Route of Administration
        • 6.3.2.2.3. By End-User
    • 6.3.3. Mexico Topical Drug Delivery Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Route of Administration
        • 6.3.3.2.3. By End-User

7. Europe Topical Drug Delivery Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Route of Administration
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Topical Drug Delivery Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By End-User
    • 7.3.2. United Kingdom Topical Drug Delivery Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By End-User
    • 7.3.3. Italy Topical Drug Delivery Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By End-User
    • 7.3.4. France Topical Drug Delivery Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Route of Administration
        • 7.3.4.2.3. By End-User
    • 7.3.5. Spain Topical Drug Delivery Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Route of Administration
        • 7.3.5.2.3. By End-User

8. Asia-Pacific Topical Drug Delivery Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Route of Administration
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Topical Drug Delivery Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By End-User
    • 8.3.2. India Topical Drug Delivery Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By End-User
    • 8.3.3. Japan Topical Drug Delivery Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By End-User
    • 8.3.4. South Korea Topical Drug Delivery Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By End-User
    • 8.3.5. Australia Topical Drug Delivery Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By End-User

9. South America Topical Drug Delivery Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Route of Administration
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Topical Drug Delivery Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By End-User
    • 9.3.2. Argentina Topical Drug Delivery Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By End-User
    • 9.3.3. Colombia Topical Drug Delivery Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By End-User

10. Middle East and Africa Topical Drug Delivery Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Route of Administration
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Topical Drug Delivery Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By End-User
    • 10.3.2. Saudi Arabia Topical Drug Delivery Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By End-User
    • 10.3.3. UAE Topical Drug Delivery Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Topical Drug Delivery Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Johnson & Johnson Services, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Nestle SA
  • 14.3. GlaxoSmithKline Plc
  • 14.4. Novartis AG
  • 14.5. Merck & Co. Inc.
  • 14.6. Crescita Therapeutics Inc.
  • 14.7. Cipla Ltd.
  • 14.8. Taro Pharmaceutical Industries Ltd.
  • 14.9. Valeant Pharmaceuticals International Inc.
  • 14.10.Glenmark Pharmaceuticals Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer